Literature DB >> 1528959

Psychiatric phenomenology in Cushing's disease.

P T Loosen1, B Chambliss, C R DeBold, R Shelton, D N Orth.   

Abstract

We evaluated 20 patients with Cushing's disease (i.e., Cushing's syndrome due to ACTH-secreting pituitary microadenoma) and 20 patients with Major Depressive Disorder (MDD) using the Structured Clinical Interview for DSM-III-R (SCID) and Research Diagnostic Criteria. The diagnosis of Generalized Anxiety Disorder (GAD) was most common in Cushing's disease (79%), followed by MDD (68%), and Panic Disorder (PD) including subthreshold PD (53%). The combination of MDD and GAD and/or PD was also common in Cushing's disease (63%). Behavioral symptoms, if present, usually first occurred at or after the onset of the first physical symptoms. However, the onset of PD was associated with more chronic stages of Cushing's disease. In both Cushing's disease and MDD, more female than male relatives suffered from MDD, whereas more male than female relatives suffered from substance abuse. The data demonstrate a syndrome of anxious depression in patients with active Cushing's disease; such comorbidility has not been previously noted. The data also point to intriguing epidemiological, clinical, and biological associations between Cushing's disease, MDD and substance abuse.

Entities:  

Mesh:

Year:  1992        PMID: 1528959     DOI: 10.1055/s-2007-1014405

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  22 in total

1.  White matter involvement on DTI-MRI in Cushing's syndrome relates to mood disturbances and processing speed: a case-control study.

Authors:  Patricia Pires; Alicia Santos; Yolanda Vives-Gilabert; Susan M Webb; Aitor Sainz-Ruiz; Eugenia Resmini; Iris Crespo; Manel de Juan-Delago; Beatriz Gómez-Anson
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  Structural and Functional Consequences of Hypercortisolism on Brain: Are the Brain and Psycho-neuro-cognitive Manifestations Reversible?

Authors:  Mahendra Kumar Garg; Madhukar Mittal
Journal:  Indian J Endocrinol Metab       Date:  2021-01-12

Review 4.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Iatrogenic Cushing's syndrome due to nasal betamethasone: a problem not to be sniffed at!

Authors:  C M Nutting; S R Page
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

Review 6.  Adverse psychological effects of corticosteroids in children and adolescents.

Authors:  F A Stuart; T Y Segal; S Keady
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

7.  Evaluation of depression, quality of life and body image in patients with Cushing's disease.

Authors:  Nilufer Alcalar; Sedat Ozkan; Pinar Kadioglu; Ozlem Celik; Penbe Cagatay; Baris Kucukyuruk; Nurperi Gazioglu
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

8.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

9.  THE MULTIFARIOUS CUSHING'S - LESSONS FROM A CASE SERIES.

Authors:  I Ilie; V Ciubotaru; A Tulin; D Hortopan; A Caragheorgheopol; M Purice; C Neamtu; V I Elian; A Banica; L Oprea; M Musat
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

Review 10.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.